Cericlamine | |
---|---|
Molecular structure via molpic based on CDK |
Conformer [] | |
---|---|
Conformer structure via JSmol |
Physical properties [] | |
---|---|
Molecular mass | 262.17 g/mol [1] |
Predicted LogP | 3 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C12H17Cl2NO [1] |
IUPAC name | 3-(3,4-dichlorophenyl)-2-(dimethylamino)-2-methylpropan-1-ol [1] |
SMILES | CC(CC1=CC(=C(C=C1)Cl)Cl)(CO)N(C)C [1] |
InChI | InChI=1S/C12H17Cl2NO/c1-12(8-16,15(2)3)7-9-4-5-10(13)11(14)6-9/h4-6,16H,7-8H2,1-3H3 [1] |
InChIKey | FWYRGHMKHZXXQX-UHFFFAOYSA-N [1] |
Dosing [] | |
---|---|
Elimination half-life | 8 hours |
Cericlamine
Cericlamine (also known as cericlamina, cericlaminum, 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol, 3-(3,4-Dichlorophenyl)-2-(dimethylamino)-2-methyl-1-propanol or 3-(3,4-Dichlorophenyl)-2-(dimethylamino)-2-methyl-1-propanol.) is a
Chemistry
Stereochemistry []
Cericlamine is a racemic mixture of the optical stereoisomers
Stereoisomers |
---|
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 131074, Cericlamine. Accessed July 13, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/131074
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Cericlamine. UNII: VES82D23IB. Global Substance Registration System. Accessed July 13, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/VES82D23IB